Evaluation of the effect of Diaphragmatic Breathing on clinical and functional outcomes in children and adolescents with Asthma: a randomized controlled trial
Not Applicable
Recruiting
- Conditions
- Asthmaanxiety disorders
- Registration Number
- RBR-3x8py3n
- Lead Sponsor
- Programa de Pós-graduação em Ciências da Saúde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
partially controlled asthma; uncontrolled asthma
Exclusion Criteria
bronchopulmonary dysplasia; cystic fibrosis; congenital cardiopulmonary diseases; immunodeficiency; chronic encephalopathy; psychomotor deficiencies
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main primary outcome of the study will be asthma control, determined through a validated questionnaire - the Asthma Control Test (ACT) ;Assess anxiety levels. Anxiety symptoms in children and adolescents will be assessed using the Spence Children's Anxiety Scale -SCAS. ;Assess basal cortisol levels by quantifying cortisol levels in salivary samples.;The severity of the airflow obstruction will be evaluated through the peak flow test, which will provide us with the forced expiratory volume.;Autonomic modulation will be evaluated through analysis of heart rate variability (HRV). Low frequency (LF = 0.04 to 0.15 Hz) and high frequency (HF = 0.15 to 0.40 Hz) spectral components expressed in normalized units (nu) are used, as well as the LF/ HF in milliseconds squared (ms²). The autonomic balance will be assessed by analyzing the HRV collected through the blood volume pulse (BVP) collected at rest and in the lying position during breathing exercise.
- Secondary Outcome Measures
Name Time Method Decreased use of medication, this outcome will be evaluated through the record of clinical conduct.